MMP14, matrix metallopeptidase 14, 4323

N. diseases: 340; N. variants: 7
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.230 AlteredExpression disease BEFREE MT1-MMP expressed by VSMCs plays a key role in limiting the progression of atherosclerosis in APOE-null mice by regulating proliferative responses and inhibiting the deterioration of VSMC function in atherogenic vascular walls. 28735290 2017
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.230 GeneticVariation disease BEFREE The traditional atherosclerosis risk factors were recorded, and the MMP 14 polymorphism were genotyped by Applied Biosystems 7300 Real-Time PCR System using the TaqMan assay. 24472034 2014
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.230 Biomarker disease BEFREE These results suggested that MT1-MMP was involved in vascular inflammation and might be a good target for treating atherosclerosis. 25490770 2014
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.230 Biomarker disease RGD Upregulation of extracellular matrix metalloproteinase inducer (EMMPRIN) and gelatinases in human atherosclerosis infected with Chlamydia pneumoniae: the potential role of Chlamydia pneumoniae infection in the progression of atherosclerosis. 12526080 2002